Published in Am J Med on August 01, 2005
Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis (2007) 3.02
HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med (2010) 3.00
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med (2009) 2.48
Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care (2007) 2.06
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology (2009) 2.00
From Bedside to Bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults. Aging Clin Exp Res (2008) 1.96
A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med (2007) 1.92
The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort. AIDS (2013) 1.92
Intervention to influence behaviors linked to risk of chronic diseases: a multisite randomized controlled trial with African-American HIV-serodiscordant heterosexual couples. Arch Intern Med (2011) 1.62
Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil. PLoS One (2008) 1.56
Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model. Ann Intern Med (2008) 1.55
Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence? Clin Infect Dis (2009) 1.54
Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives? J Int AIDS Soc (2011) 1.36
Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav (2010) 1.27
Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann Intern Med (2008) 1.23
Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med (2007) 1.19
Effect of cigarette smoking on HIV acquisition, progression, and mortality. AIDS Educ Prev (2009) 1.17
Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status. Clin Infect Dis (2008) 1.13
Influence of alcohol consumption on adherence to and toxicity of antiretroviral therapy and survival. Alcohol Res Health (2010) 1.08
HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr (2013) 1.07
Averting HIV infections in New York City: a modeling approach estimating the future impact of additional behavioral and biomedical HIV prevention strategies. PLoS One (2013) 1.07
HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc (2011) 1.05
Prescription long-term opioid use in HIV-infected patients. Clin J Pain (2012) 1.05
Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity. Am J Physiol Endocrinol Metab (2010) 1.03
Patient and provider-reported symptoms in the post-cART era. AIDS Behav (2011) 1.01
Incorporating quality of evidence into decision analytic modeling. Ann Intern Med (2007) 1.01
A mixed-methods approach to understanding barriers to postpartum retention in care among low-income, HIV-infected women. AIDS Patient Care STDS (2015) 0.99
The interplay of sociodemographic factors on virologic suppression among a U.S. outpatient HIV clinic population. AIDS Patient Care STDS (2010) 0.97
Cigarette smoking, illicit drug use, and routes of administration among heroin and cocaine users. Addict Behav (2012) 0.95
Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Sex Transm Infect (2010) 0.95
Critical illness in HIV-infected patients in the era of combination antiretroviral therapy. Proc Am Thorac Soc (2011) 0.92
Gender differences in baseline health, needs at release, and predictors of care engagement among HIV-positive clients leaving jail. AIDS Behav (2013) 0.90
Pathogenesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef. Proc Am Thorac Soc (2011) 0.89
Factors associated with abnormal spirometry among HIV-infected individuals. AIDS (2015) 0.87
Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects. Respir Res (2011) 0.85
Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value? Value Health (2010) 0.85
Number of Drinks to "Feel a Buzz" by HIV Status and Viral Load in Men. AIDS Behav (2016) 0.84
Moderate-Intensity Exercise Improves Body Composition and Improves Physiological Markers of Stress in HIV-Infected Men. ISRN AIDS (2012) 0.84
Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort. J Acquir Immune Defic Syndr (2016) 0.82
Definition of advanced age in HIV infection: looking for an age cut-off. AIDS Res Hum Retroviruses (2012) 0.82
HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV. Eur J Med Res (2009) 0.81
Update on the Epidemiology and Prevention of HIV/AIDS in the United States. Curr Epidemiol Rep (2015) 0.80
Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa. Value Health (2015) 0.80
Evolving clinical phenotypes in HIV-associated neurocognitive disorders. Curr Opin HIV AIDS (2014) 0.79
Cost-effectiveness of the third-agent class in treatment-naive human immunodeficiency virus-infected patients in Portugal. PLoS One (2012) 0.77
Depression symptoms and treatment among HIV infected and uninfected veterans. AIDS Behav (2008) 0.77
Using mechanistic models to simulate comparative effectiveness trials of therapy and to estimate long-term outcomes in HIV care. Med Care (2010) 0.76
Childhood sexual abuse and depression in Latino men who have sex with men: Does resilience protect against nonadherence to antiretroviral therapy? J Health Psychol (2014) 0.75
Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol. BMC Public Health (2017) 0.75
Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients. Drug Alcohol Depend (2016) 0.75
Should expectations about the rate of new antiretroviral drug development impact the timing of HIV treatment initiation and expectations about treatment benefits? PLoS One (2014) 0.75
The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population. BMC Public Health (2016) 0.75
HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights. Value Health (2015) 0.75
Betting on the fastest horse: Using computer simulation to design a combination HIV intervention for future projects in Maharashtra, India. PLoS One (2017) 0.75
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res (2007) 14.84
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis (2013) 10.92
Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95
HIV infection and the risk of acute myocardial infarction. JAMA Intern Med (2013) 5.90
Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology (2003) 5.40
What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care (2008) 5.14
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet (2006) 5.00
Brief intervention for medical inpatients with unhealthy alcohol use: a randomized, controlled trial. Ann Intern Med (2007) 4.73
Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med (2007) 4.54
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis (2008) 4.46
Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc (2003) 4.44
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS (2007) 4.31
Development and verification of a "virtual" cohort using the National VA Health Information System. Med Care (2006) 4.28
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med (2015) 3.75
Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol (2007) 3.46
A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res (2005) 3.21
Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr (2007) 3.14
Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis (2007) 3.02
Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA (2008) 3.01
HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med (2010) 3.00
Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women. Ann Intern Med (2011) 2.96
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
Increased COPD among HIV-positive compared to HIV-negative veterans. Chest (2006) 2.93
Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. Value Health (2012) 2.86
Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med (2010) 2.60
The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med (2005) 2.58
Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS (2005) 2.56
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50
Procuring organ donors as a health investment: how much should we be willing to spend? Transplantation (2004) 2.47
Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry (2006) 2.41
Is survival better at hospitals with higher "end-of-life" treatment intensity? Med Care (2010) 2.35
Rate and predictors of treatment prescription for hepatitis C. Gut (2006) 2.31
Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy. Stat Med (2004) 2.26
Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS (2007) 2.24
Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clin Infect Dis (2014) 2.24
Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation (2012) 2.24
Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Making (2012) 2.21
Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis (2003) 2.19
Considerations in the statistical analysis of hemodialysis patient survival. J Am Soc Nephrol (2009) 2.18
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. Am J Public Health (2003) 2.16
How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr (2003) 2.14
Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One (2011) 2.11
A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol (2003) 2.10
Hepatitis C treatment completion rates in routine clinical care. Liver Int (2009) 2.10
HIV infection and the risk of diabetes mellitus. AIDS (2009) 2.10
The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care (2009) 2.10
Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. Med Decis Making (2005) 2.10
Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis (2009) 2.10
Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr (2009) 2.09
A higher sense of purpose in life is associated with sexual enjoyment in midlife women. Menopause (2011) 2.09
Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. Arch Intern Med (2011) 2.08
Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med (2015) 2.07
Influence of race on inpatient treatment intensity at the end of life. J Gen Intern Med (2007) 2.07
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05
Spirituality and religion in patients with HIV/AIDS. J Gen Intern Med (2006) 1.99
Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection. Hepatology (2004) 1.97
A systematic review of stakeholder engagement in comparative effectiveness and patient-centered outcomes research. J Gen Intern Med (2014) 1.93
A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med (2007) 1.92
Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics (2003) 1.92
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Outcomes of mild cognitive impairment by definition: a population study. Arch Neurol (2011) 1.84
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther (2008) 1.83
Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume. Ann Intern Med (2007) 1.81
Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf (2011) 1.76
Racial variation in end-of-life intensive care use: a race or hospital effect? Health Serv Res (2006) 1.76
Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol (2003) 1.73
Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev (2009) 1.72
Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med (2013) 1.71
Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial. Sex Transm Infect (2007) 1.70
Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. Nicotine Tob Res (2011) 1.69
Outcomes after out-of-hospital endotracheal intubation errors. Resuscitation (2008) 1.69
Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl (2004) 1.69
Virtual epidemic in a virtual city: simulating the spread of influenza in a US metropolitan area. Transl Res (2008) 1.68
Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med (2005) 1.66
An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS (2013) 1.64
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med (2014) 1.64
Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin Infect Dis (2008) 1.62
The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circ Cardiovasc Qual Outcomes (2011) 1.62
Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials. Ann Intern Med (2015) 1.61
Economic evaluation of standing order programs for pneumococcal vaccination of hospitalized elderly patients. Infect Control Hosp Epidemiol (2008) 1.61
Development and validation of hospital "end-of-life" treatment intensity measures. Med Care (2009) 1.58
Creatinine production, nutrition, and glomerular filtration rate estimation. J Am Soc Nephrol (2003) 1.57
Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl (2002) 1.57
Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med (2002) 1.57
Alcohol and drug use and related disorders: An underrecognized health issue among adolescents and young adults attending sexually transmitted disease clinics. Sex Transm Dis (2006) 1.57